Longitudinal assessment of sNfL and sGFAP in severe NMOSD treated with allogeneic stem cell transplantation - Top-Institutions - MDSpire

Longitudinal assessment of sNfL and sGFAP in severe NMOSD treated with allogeneic stem cell transplantation

  • By

  • Barbora Srpova

  • Eva Krasulova

  • Libuse Noskova

  • Michaela Cichrova

  • Marta Kalousova

  • Veronika Valkova

  • Marek Trneny

  • Vlastimil Kral

  • Eva Kubala Havrdova

  • Petra Nytrova

  • July 1, 2026

  • 0 min

Share

Top Institutions in Neurology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, Minnesota

    Key Differentiators

    • Neurology
    • Multiple Sclerosis

  • #2

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, Massachusetts

    Key Differentiators

    • Neurology
    • Multiple Sclerosis

Original Source(s)

Longitudinal assessment of sNfL and sGFAP in severe NMOSD treated with allogeneic stem cell transplantation

  • by Barbora Srpova, Eva Krasulova, Libuse Noskova, Michaela Cichrova, Marta Kalousova, Veronika Valkova, Marek Trneny, Vlastimil Kral, Eva Kubala Havrdova, Petra Nytrova

  • July 1, 2026

Related Content

Risk factors and mediating mechanisms of restless legs syndrome in patients undergoing maintenance hemodialysis: a longitudinal cohort study combined with Mendelian randomization analysis

Blood-activating, depression-relieving formula alleviates post-stroke depression: mechanistic insights from network pharmacology and microglial validation

Headache service quality in Egypt: current status, identified gaps, and strategic directions